Herbert Conrad

Biography

Mr. Conrad became the Chairman of the Board of Matinas BioPharma in 2012. He also serves as a Director on the Board of Celldex and as an Advisor to the Seaver Autism Center at Mount Sinai Hospital. Mr. Conrad was the former President of Roche Pharmaceuticals in the United States from 1982 until his retirement in 1993. Since then he has served on the boards of Pharmasset (Chairman), Savient, Dura, UroCor, GenVec (Chairman), Sicor, Bone Care International (Chairman), Sapphire Therapeutics (Chairman), the medical advisory board of Henry Schein, and he was a Director and co-founder of Reliant Pharmaceuticals. He received B.S. and M.S. degrees from the Brooklyn College of Pharmacy and an honorary Doctorate in Humane Letters from Long Island University. 

Research Interest

Therapeutics